International Patent: PEGYLATED LIPID NANOPARTICLES MODIFIED WITH CELL PENETRATING PEPTIDES FOR DELIVERY OF NUCLEIC ACIDS

GENEVA, Sept. 7 -- ORION THERAPEUTICS, INC. filed a patent application (US2026/017032) for “PEGYLATED LIPID NANOPARTICLES MODIFIED WITH CELL PENETRATING PEPTIDES FOR DELIVERY OF NUCLEIC ACIDS”. With publication no. WO/2026/183439, here are the other details related to the patent application:

Kind: Initial Publication with ISR [A1]

IPC: A61K 9/51

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Disclaimer: Curated by HT Syndication....